First-in-patient study of the GDF-15 inhibitor ponsegromab in patients with cancer and cachexia: Safety, tolerability, and exploratory measures of efficacy

Jeffrey Crawford,Roberto A. Calle,Susie M. Collins,Yan Weng, Shannon L. Lubaczewski, Clare Buckeridge,Ellen Q. Wang,Magdalena A. Harrington,Anil Tarachandani, Michelle I. Rossulek, James H. Revkin

CANCER RESEARCH(2023)

Cited 0|Views3
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined